MTOR and tuberous sclerosis: Having recognized angiogenic growth factors, an inflammatory response, and induced translation of the protein synthesis machinery as altered disease-relevant mechanisms in our TSC model with mTOR hyperfunction, we set out to investigate the therapeutic molecular effects of mTOR inhibitors.